Alkali therapy protects renal function, suppresses inflammation, and improves cellular metabolism in kidney disease
Chronic kidney disease (CKD) affects approximately 10-13% of the population worldwide and halting its progression is a major clinical challenge. Metabolic acidosis is both a consequence and a possible driver of CKD progression. Alkali therapy counteracts these effects in CKD patients, but underlying...
Main Authors: | Amann, K. (Author), Bourgeois, S. (Author), Imenez Silva, P.H (Author), Joller, N. (Author), Mohebbi, N. (Author), Pastor Arroyo, E.M (Author), Russo, G. (Author), Sakiri, E. (Author), Wagner, C.A (Author), Yassini, N. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
The Prevalence of Metabolic Acidosis in Patients with Different Stages of Chronic Kidney Disease: Single-Centre Study
by: Piotr Kuczera, et al.
Published: (2020-10-01) -
Exhausted Capacity of Bicarbonate Buffer in Renal Failure Diagnosed Using Point of Care Analyzer
by: Tomasz Gołębiowski, et al.
Published: (2021-02-01) -
Augmented Clearance of Nivolumab Is Associated with Renal Functions in Chronic Renal Disease Model Rats
by: Enoki, Y., et al.
Published: (2022) -
Acid Balance, Dietary Acid Load, and Bone Effects—A Controversial Subject
by: Lynda Frassetto, et al.
Published: (2018-04-01) -
Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease
by: Roswitha Siener
Published: (2018-04-01)